TRUMPET - Treatment Registry for Outcomes in CRPC Patients

Pontchartrain Cancer Center is involved in a registry study for men with advanced prostate cancer. The registry will involve around 2000 men across the United States, and up to 200 study centers. 

Collecting information from such a large group of men may help us understand more about how doctors are treating this type of cancer in the US, and how their decisions affect the people they treat. We hope this information will help to improve the care of men with prostate cancer in the future. Pontchartrain is excited to be taking part in the TRUMPET Registry.